Risk of acute kidney injury in patients receiving vancomycin and concomitant piperacillin-tazobactam or carbapenem: a multicenter, retrospective cohort study
The prevalence of AKI was found to be higher in patients receiving VAN+PTZ therapy compared to those receiving VAN+CBP therapy based on creatinine-defined AKI.
Authors
- Xiuli Chai
- Lulu Zhou (ORCID: https://orcid.org/0009-0004-0990-1259)
- Xiaowu Wang (ORCID: https://orcid.org/0000-0001-6753-227X)
- Guanglin Li (ORCID: https://orcid.org/0000-0001-9016-2617)
- Dong Wu
- Shaobo Guo (ORCID: https://orcid.org/0000-0002-9265-5690)
Institutions
- Wannan Medical College (CN)
- Fuyang City People's Hospital (CN)
- Xian Yang Central Hospital (CN)
- Wuxi People's Hospital (CN)
- Fuyang Second People's Hospital (CN)
- Qiannan Normal College For Nationalities (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1080/14740338.2024.2393263
- Citations
- 1
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.45